# A Phase II Trial of 18F-AV-45 Positron Emission Tomography (PET) Imaging in Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)

> **NCT00702143** · PHASE2 · COMPLETED · sponsor: **Avid Radiopharmaceuticals** · enrollment: 184 (actual)

## Conditions studied

- Alzheimer's Disease
- Mild Cognitive Impairment

## Interventions

- **DRUG:** florbetapir F 18

## Key facts

- **NCT ID:** NCT00702143
- **Lead sponsor:** Avid Radiopharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 184 (ACTUAL)
- **Last updated:** 2012-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00702143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00702143, "A Phase II Trial of 18F-AV-45 Positron Emission Tomography (PET) Imaging in Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00702143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*